Criteria for discontinuing or modifying allocated interventions
RECRUITMENT
If the inclusion and/or exclusion criteria are contravened after recruitment, these patients will be removed from the trial. Dropouts from this trial will receive adjuvant RT with or without 20 mg tamoxifen based on clinicopathological features. For these patients, their clinical data and treatment characteristics will be retained, unless they unambiguously refuse.